Rituximab can be used to treat focal segmental glomerulosclerosis.
At present, Rituximab has been widely used in the treatment of many types of intractable kidney diseases in clinic, especially those that cannot be relieved by traditional treatment programs, such as the common focal segmental glomerulosclerosis, lupus nephritis, vasculitis renal damage and other diseases, which have obvious efficacy.
As most of the focal segmental glomerulosclerosis is poorly treated by applying traditional treatments, it can be treated with rituximab, but due to the relatively high cost of rituximab treatment, as well as the drug has certain side effects, such as infection.
The use of rituximab needs to be under the guidance of a professional doctor to use the drug, and during the use of the drug, to develop good habits, to avoid staying up late for a long time, if the use of the drug adverse reactions, to the hospital in a timely manner to seek medical treatment.